Anaplastic thyroid cancer is one of the rarest and most aggressive forms of thyroid cancer. Early and accurate diagnosis is crucial because this disease grows extremely fast and requires immediate attention. Understanding the diagnostic process can help patients and their families know what to expect and why speed matters in getting the right answers.

Introduction: Who Should Undergo Diagnostics

Anyone who notices a rapidly growing lump on the front of their neck should seek medical evaluation right away. Unlike most thyroid cancers, which develop slowly and often without symptoms, anaplastic thyroid cancer makes itself known quickly. The lump typically appears suddenly, sometimes growing noticeably over just a few weeks. This mass is usually hard to the touch, almost rock-like, and can be both seen and felt by the patient.^[1]

People who should especially consider urgent medical evaluation include those experiencing compressive symptoms. These are problems caused when the tumor presses on nearby structures in the neck. You might find it difficult to swallow food or pills, feeling as though something is stuck in your throat. Some patients experience pressure or shortness of breath, particularly when lying flat. Voice changes, including hoarseness or difficulty controlling your voice, are also warning signs that should never be ignored. Other concerning symptoms include persistent cough, loud breathing sounds, or even paralysis of the vocal cords.^[1][4]

If you have a history of other thyroid problems, you should be particularly alert. People with a long-standing goiter (an enlarged thyroid gland) or a history of papillary or follicular thyroid cancers face higher risk. This is because anaplastic thyroid cancer sometimes develops from these less aggressive thyroid cancers that were present earlier. The cancer essentially transforms into a more dangerous form.^[1][2]

Age also matters. Anaplastic thyroid cancer most commonly affects people over 60 years old, though it can occur at any age. Women are slightly more likely than men to develop this cancer, though the difference is not as pronounced as with other thyroid cancers. Anyone who has had radiation exposure to the chest or neck area in the past should also be vigilant about unusual neck symptoms.^[4][6]

Diagnostic Methods

Initial Examination and Biopsy

The diagnostic journey typically begins when a doctor physically examines your neck and feels the lump. However, the definitive way to diagnose anaplastic thyroid cancer is through a biopsy, which means taking a small sample of tissue from the tumor to examine under a microscope. The most common first approach is a fine needle aspiration, often abbreviated as FNA or FNAB. During this procedure, your doctor inserts a very thin needle into the mass on your thyroid and withdraws a small tissue sample. This is typically done in an office setting and causes minimal discomfort.^[1][3]

A skilled pathologist (a doctor who specializes in examining tissues) will then look at the sample under a microscope. They search for cancer cells and, if found, determine what type of thyroid cancer it is. The cells in anaplastic thyroid cancer look very abnormal and don’t resemble normal thyroid cells at all. This is why this cancer is also called undifferentiated thyroid cancer—the cells have lost the characteristics that would identify them as thyroid cells.^[1][2]

Sometimes a fine needle aspiration doesn’t provide enough tissue for a clear diagnosis. This is especially true when trying to distinguish anaplastic thyroid cancer from other conditions that can look similar, such as thyroid lymphoma or aggressive forms of medullary thyroid cancer. In these cases, doctors may recommend a core needle biopsy, which uses a larger needle to obtain a bigger tissue sample. This procedure is more sensitive and specific than fine needle aspiration, meaning it’s better at correctly identifying the disease. In rare situations where needle biopsies don’t give clear answers, a surgical biopsy might be necessary.^[3][4]

Imaging Tests to Assess Disease Extent

Once anaplastic thyroid cancer is diagnosed through biopsy, the next critical step is determining how far the disease has spread. This process is called staging, and it requires several imaging tests. These tests help doctors see the size of the tumor, whether it has invaded nearby structures, and if it has spread to distant parts of the body.^[1]

A CT scan (computed tomography scan) of the neck and chest is usually one of the first imaging studies performed. This test uses X-rays taken from multiple angles and combines them with computer processing to create detailed cross-sectional images of your body. The CT scan can show how large the tumor is and whether it’s invading nearby structures such as muscles, the trachea (windpipe), or the esophagus (food pipe). It can also detect if cancer has spread to lymph nodes in the neck or to the lungs, which is a common site of spread for this cancer.^[1][4]

An MRI (magnetic resonance imaging) scan may also be ordered. MRI uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues. This can be particularly helpful for seeing the relationship between the tumor and important structures like blood vessels and nerves in the neck.^[1]

A PET scan, specifically F-fluorodeoxyglucose positron emission tomography, is another important tool. This type of scan uses a small amount of radioactive sugar that cancer cells absorb more readily than normal cells. The scan can light up areas where cancer is active throughout the body, helping doctors identify spread to distant organs such as bones, lungs, or brain. This information is crucial for planning treatment.^[1]

Additional Diagnostic Procedures

Because anaplastic thyroid cancer can affect the vocal cords and breathing passages, doctors often perform a flexible laryngoscopy. This involves inserting a thin, flexible tube with a camera through the nose or mouth and down the throat. The procedure allows the doctor to look directly at the vocal cords and determine if they have been affected by the cancer. This information is important both for diagnosis and for planning any potential surgery or interventions to protect the airway.^[4]

Blood tests are also part of the diagnostic workup, though they don’t diagnose the cancer itself. These tests help assess your overall health and organ function, which is important when planning treatment. Thyroid function tests are usually normal in people with anaplastic thyroid cancer, unlike some other thyroid conditions where hormone levels are abnormal.^[5]

Understanding Your Diagnosis Stage

Something unique about anaplastic thyroid cancer is that all cases are automatically classified as stage IV. This is different from most other cancers, where staging depends on tumor size and how far it has spread. With anaplastic thyroid cancer, the disease is so aggressive that it’s considered advanced at diagnosis regardless of size. However, stage IV is divided into three substages based on how far the cancer has spread.^[1][11]

Stage IVA means the cancer is only in your thyroid gland. This happens in about 10% of cases. Stage IVB indicates the cancer is in your thyroid and has spread to nearby areas in the neck, typically lymph nodes, but hasn’t reached other parts of the body. This occurs in approximately 40% of cases. Stage IVC means the cancer has spread throughout your body to distant organs such as bones, lungs, or brain. Unfortunately, this is found in about 50% of cases at the time of diagnosis.^[1][11]

Diagnostics for Clinical Trial Qualification

Standard Baseline Assessments

When considering participation in a clinical trial for anaplastic thyroid cancer, certain diagnostic tests are typically required to determine if you meet the eligibility criteria. These tests serve multiple purposes: they confirm your diagnosis, establish your current health status, and provide baseline measurements that researchers will use to evaluate whether the experimental treatment is working.^[3]

All clinical trials require confirmed tissue diagnosis through biopsy. The biopsy sample must clearly show anaplastic thyroid cancer cells. Most trials want this confirmed by a pathologist who is experienced in examining thyroid cancers. Sometimes, trials require that the biopsy tissue be sent to a central laboratory for review to ensure consistent diagnosis across all participants.^[3]

Complete imaging studies are essential for trial enrollment. This typically includes CT scans of the neck and chest, and often a PET scan as well. These images document the extent of disease before treatment begins, creating a baseline against which future scans will be compared to see if the treatment is shrinking the tumors, keeping them stable, or if the disease is progressing. Trials usually require these scans to be recent, often within two to four weeks of starting the experimental treatment.^[3]

Molecular and Genetic Testing

One of the most important diagnostic tests for clinical trial eligibility is molecular testing of the tumor tissue. This involves analyzing the cancer cells to look for specific genetic mutations or abnormalities. Over recent years, scientists have discovered that anaplastic thyroid cancers have several characteristic genetic changes, and some targeted therapies work specifically against tumors with certain mutations.^[3]

A BRAF mutation analysis is now considered mandatory for anaplastic thyroid cancer patients. BRAF is a gene that, when mutated in a specific way (called BRAFV600E), can be targeted by certain medications. Approximately half of anaplastic thyroid cancers have BRAF mutations. If your tumor tests positive for this mutation, you may be eligible for clinical trials testing BRAF-targeted drugs such as dabrafenib combined with trametinib. In fact, this combination has already been approved by the Food and Drug Administration for patients with locally advanced or metastatic anaplastic thyroid cancer who have the BRAFV600E mutation.^[12][15]

Broader genetic testing using next-generation sequencing is increasingly recommended. This technology can examine many genes at once, looking for a wide range of mutations. Anaplastic thyroid cancers often have multiple genetic abnormalities, and identifying these can open doors to specific clinical trials. For example, some tumors have mutations in genes called RET or NTRK, which can be targeted by specific drugs available in clinical trials. Others may have mutations in the PI3K or mTOR pathways, which are targets for other investigational therapies.^[3][15]

Some clinical trials also test for PD-L1 expression in tumor cells. PD-L1 is a protein that cancer cells sometimes use to hide from the immune system. Tumors with high PD-L1 expression may respond better to immunotherapy drugs, which help the immune system recognize and attack cancer cells. If your tumor shows PD-L1 positivity, you might be eligible for trials testing immunotherapy medications such as pembrolizumab or spartalizumab, either alone or in combination with other treatments.^[6][15]

Performance Status and Organ Function Tests

Clinical trials have specific requirements about your overall health and ability to function. Doctors assess your performance status, which is a measure of how well you can carry out daily activities. This is usually scored on a standardized scale. Trials typically require that you be well enough to care for yourself and be up and about for at least half of your waking hours, even if you can’t work.^[3]

Blood tests to check organ function are standard for trial eligibility. These include tests of kidney function, liver function, and blood cell counts. The experimental treatment must be safe for you, and if your organs aren’t functioning well enough, certain therapies could be dangerous. Specific blood tests might include measurements of creatinine (for kidney function), liver enzymes, bilirubin, and complete blood counts to check your red blood cells, white blood cells, and platelets.^[3]

If the tumor is near your airway and causing breathing problems, doctors may perform pulmonary function tests to measure how well your lungs are working. Heart function tests, such as an electrocardiogram or echocardiogram, might be required before starting certain targeted therapies that can affect the heart.^[3]

Documenting Previous Treatments

For patients who have already received some treatment before considering a clinical trial, detailed documentation of those previous therapies is required. This includes records of any surgery performed, the extent of tumor removal, radiation therapy details (including dose and treatment area), and any chemotherapy or targeted drugs already tried. Researchers need this information to understand how your cancer has behaved and to ensure that previous treatments don’t make you ineligible for the trial they’re offering.^[3]

The timing of previous treatments matters too. Some trials require a waiting period after your last radiation or chemotherapy before you can start the experimental treatment. This allows your body to recover from the effects of previous therapy and helps researchers clearly see the effects of the new treatment being tested.^[3]